Does low bone density influence symptoms and functional status in patients with fibromyalgia? Observations from rural South India

The presence of more than one musculoskeletal disease has been found to impair quality of life (QoL). The influence of low bone mineral density ( BMD ) on symptoms and function in those with fibromyalgia syndrome ( FMS ) is unknown. Methodology A cross sectional study was carried out on 158 patients attending camps in rural South India. BMD was determined using quantitative ultrasound of the distal radius. Symptoms and function were assessed using a visual analogue scale ( VAS ) and the Fibromyalgia Impact Questionnaire ( FIQ ). Results Low BMD was seen in 81.6% (129/158) of the persons screened. FMS was seen in 37/158 persons, of which 31/37 (83.7%) had low BMD . Conclusion FMS with low bone density leads to higher levels of pain and a poorer QoL compared to those without FMS . Coexisting musculoskeletal problems could also contribute to this. Therefore, medical practitioners and rehabilitation specialists should consider screening for bone density among those with FMS and should use this information to decide appropriate therapies to reduce pain and improve QoL.